+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

GLCCI1 and Glucocorticoid Receptor Genetic Diversity and Response to Glucocorticoid-Based Treatment of Graft-versus-Host Disease

GLCCI1 and Glucocorticoid Receptor Genetic Diversity and Response to Glucocorticoid-Based Treatment of Graft-versus-Host Disease

Biology of Blood and Marrow Transplantation 21(7): 1246-1250

The genetic diversity of loci implicated in glucocorticoid (GC) response has been associated with interindividual variations in responsiveness to GC in various diseases, such as asthma and inflammatory bowel disorders. In acute graft-versus-host disease (aGVHD), similar differences of first-line therapy responsiveness are also observed, with approximately 40% of patients failing to respond to GC. Here, the distribution of functionally relevant single nucleotide polymorphisms (SNP) belonging to the GC-induced transcript 1 GLCCI1 (rs37972) and the glucocorticoid receptor (rs41423247, rs6195 and rs6198) gene loci were analyzed alongside clinical factors for their association with the response to corticosteroids in aGVHD. The frequencies of variant alleles did not differ significantly between corticoresistant patients, their donors, and their corticosensitive peers (P = .10 to 1.00). Severe and early onset of aGVHD, bone marrow as the stem cell source, and an HLA mismatch were associated with the failure to respond to GC in logistic regression. After including the single SNPs to the model, carriers of the rs41423247 polymorphism had a higher probability of responding to GC, whereas all other polymorphisms did not affect the likelihood of response.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 057915042

Download citation: RISBibTeXText

PMID: 25843653

DOI: 10.1016/j.bbmt.2015.03.015

Related references

Prevention of chronic graft-versus-host disease by stimulation with glucocorticoid-induced TNF receptor. Experimental & Molecular Medicine 38(1): 94-99, 2006

The glucocorticoid receptor in recipient cells keeps cytokine secretion in acute graft-versus-host disease at bay. Oncotarget 9(21): 15437-15450, 2018

A clinical phase I/II study of recombinant human interleukin-1 receptor in glucocorticoid-resistant graft-versus-host disease. Transplantation 62(5): 626-631, 1996

Polymorphisms in the glucocorticoid receptor gene and in the glucocorticoid-induced transcript 1 gene are associated with disease activity and response to glucocorticoid bridging therapy in rheumatoid arthritis. Rheumatology International 35(8): 1325-1333, 2016

Glucocorticoid-refractory acute graft-versus-host disease. Biology of Blood and Marrow Transplantation 16(11): 1504-1518, 2011

Glucocorticoid repression of transcription via a negative glucocorticoid response element involves interplay between the glucocorticoid receptor and two dna binding nuclear factors. Journal of Cellular Biochemistry Supplement (16 PART C): 21, 1992

Pentostatin as rescue therapy for glucocorticoid-refractory acute and chronic graft-versus-host disease. Annals of Transplantation 15(4): 21-29, 2011

Dysglycemia following glucocorticoid therapy for acute graft-versus-host disease adversely affects transplantation outcomes. Biology of Blood and Marrow Transplantation 17(2): 239-248, 2011

Induction of a glucocorticoid-sensitive F1-anti-parental mechanism that affects engraftment during graft-versus-host disease. Journal of Immunology 155(1): 172-180, 1995

Response of Glucocorticoid Receptor Alpha and Histone Deacetylase 2 to Glucocorticoid Treatment Predicts the Prognosis of Sudden Sensorineural Hearing Loss. Clinical and Experimental Otorhinolaryngology 2019, 2019

Pathophysiology of acute respiratory distress syndrome. Glucocorticoid receptor-mediated regulation of inflammation and response to prolonged glucocorticoid treatment. Presse Medicale 40(12 Pt 2): E543-E560, 2012

Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma. New England Journal of Medicine 365(13): 1173-1183, 2011

Early Hyperglycemia after Initiation of Glucocorticoid Therapy Predicts Adverse Outcome in Patients with Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation 23(7): 1186-1192, 2017

Ability of the glucocorticoid modulatory element to modify glucocorticoid receptor transactivation indicates parallel pathways for the expression of glucocorticoid modulatory element and glucocorticoid response element activities. Molecular & Cellular Endocrinology 162(1-2): 221-234, April 25, 2000

Characterization of glucocorticoid receptors in animal lymphoblastic disease: correlation with response to single-agent glucocorticoid treatment. Blood 63(2): 380-383, 1984